Profound Medical and OptimizeRx Post Strong 2025 Results Amid MedTech Recovery
Profound Medical and OptimizeRx reported strong fourth-quarter and full-year 2025 financial results, signaling robust growth in the interventional MRI and life sciences engagement sectors. Both companies demonstrated significant commercial progress, reflecting a broader industry shift toward minimally invasive procedures and data-driven healthcare communication.